Treasury Proposes Bans on U.S. Investment in Chinese Biotech, AI
The U.S. Treasury Department proposed restrictions on American investment in Chinese biotech, artificial intelligence and advanced memory chips. The proposal could cut off a source of new drugs for the pharmaceutical industry if adopted.